AMAT vs RNAZ · P/E 56, rev $24.04B vs $5.1M cap
Applied Materials Inc (AMAT) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
RNAZ does not have a complete income-statement cache yet.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the AMAT and RNAZ stock pages for the full models.
Not investment advice.